Conmed's Expanding Surgical Product Offerings Help Boost Stock 18% In May
This article was originally published in The Gray Sheet
Executive Summary
FDA marketing approval for Linvatec's Endopearl tissue connector for fixation of soft tissue grafts in the femoral socket during anterior cruciate ligament reconstruction, announced May 13, gave parent Conmed's stock a leg up in May.